Daylife Select
A point & click tool to create dynamic content portals. Learn More »
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
BRIDGEWATER, N.J. - A division of Johnson & Johnson said Wednesday that federal regulators granted full approval to an HIV drug designed to treat patients who have stopped responding to other treatments. Full Article at Minneapolis Star Tribune
BRIDGEWATER, N.J. A division of Johnson & Johnson said Wednesday that federal regulators granted full approval to an HIV drug designed to treat patients who have stopped responding to other treatments. Full Article at San Diego Union-Tribune
Dr. Sarit Larisch, Head of the Cell Death Research Laboratory and senior lecturer at the University of Haifa, has been awarded the prestigious Johnson & Johnson Focused Funding grant for her research exploring the cause of brain cell damage in... Full Article at AlphaGalileo,org
BabyCenter, an online resource for new and expecting parents and a part of the Johnson & Johnson group, has partnered with HP SnapFish to enable its members transfer, organize and print photos, as well as create photo gifts such as photo books,... Full Article at Alootechie
To paraphrase the bumper sticker: Stuff happens. Fortunately, so does good leadership—but those folks looking for pat solutions to unpredictable situations will be disappointed. First-rate management of a crisis rarely looks the same twice. Full Article at U.S. News & World Report
David Gardner called it. He’s up 1,334%! See what David’s recommending that you buy NEXT. Platforms aren't just for acrobatic moves before splashing into the pool or '70s night at the disco. Full Article at Motley Fool
SAN MATEO, Calif. , Nov. 24 /PRNewswire-FirstCall/ -- NeurogesX, Inc. Full Article at PR Newswire
While Berkshire Hathaway (BRK.A) (BRK.B) may have made big headlines earlier this month with its $44 billion acquisition of Burlington Northern (BNI), the company was no slouch during the third quarter, when it was actively buying and selling... Full Article at iStockAnalyst
REDWOOD CITY, Calif. , Nov. 23 /PRNewswire/ -- Pearl Therapeutics Inc. , a biopharmaceutical company developing therapeutic products for the treatment of chronic respiratory diseases, today announced the appointment of Howie Rosen to the company's Board... Full Article at RedOrbit
• Johnson & Johnson has undertaken 80 sustainability projects since 2005 and achieved $187 million in savings with an ROI of nearly 19 percent, and rising. Full Article at GreenBiz
I kicked myself for two years while the stock quadrupled. Full Article at The Money Times
Since their first appearance at Big 5 in 2005, IBW have brought nearly 100 companies over to the Middle East to participate in the exhibition to date. Full Article at AME Info
22 November 2009 Continuing their attendance at Big 5 for the fifth consecutive year, International Business Wales (IBW), the overseas trade and investment arm of the Welsh Assembly Government, will be heading a trade delegation of 9 companies... Full Article at Zawya.com
By Brett Arends Wall Street has rallied a long way since the dark days last winter. Full Article at Wall Street Journal
MARIETTA, Pa. Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. You name it, the pharmaceutical industry is working on a vaccine to prevent it. Many could be on the market in five years or less. Full Article at Louisville Courier-Journal
support has been drawing in new companies, from nascent biotechs to Johnson & Johnson. Full Article at Salt Lake Tribune
Dear Ben Bernanke and distinguished members of the Federal Reserve: We are writing today to formally solicit your help in obtaining approvals to start a new bank holding company, Money Unlimited. Full Article at Motley Fool
In a Nov. 17 story about drug interactions between heartburn medications and the blood thinner Plavix, The Associated Press misidentified Johnson & Johnson's Mylanta as part of the H-2 blocker drug family. Mylanta is an antacid. Full Article at The Seattle Times
WASHINGTON — They call it the "Botax." Full Article at Huffington Post
Drug and device makers are urging the FDA to establish clear guidelines that will allow the industry to discuss and promote products in the unsettled world of online social media. Full Article at Kevin, M.D.
There are no results for this module. Edit this module to change the search term used to query Wikipedia
A box of Johnson & Johnson BAND-AID bandages is shown, Tuesday, July 14, 2009, in Boston. Health care products maker Johnson & Johnson says its second-quarter profit fell 3.5 percent due to lower sales, particularly for its prescription drugs, and the weak dollar.
View Photo »This undtaed handout photo provided by Johnson & Johnson shows an IBOT wheelchair.
View Photo »Products made by Johnson & Johnson for sale on a store shelf in Westminster, Colorado April 14, 2009.
View Photo »A first aid kit made by Johnson & Johnson for sale on a store shelf in Westminster, Colorado April 14, 2009.
View Photo »Products made by Johnson & Johnson for sale on a store shelf in Westminster, Colorado April 14, 2009.
View Photo »Products made by Johnson & Johnson are displayed for sale on a store shelf in Westminster, Colorado April 14, 2009.
View Photo »Johnson & Johnson consumer products, Johnson's Baby Powder, Band-Aids and Tylenol, are seen in Newark, N.J. , Tuesday, April, 14, 2009.
View Photo »Johnson & Johnson consumer products, Band-Aids, Listerine, Tylenol, Johnson's Baby Powder, Neutrogena Acne Wash, Rolaids and Visine, are shown in Newark, N.J. , Tuesday, April, 14, 2009.
View Photo »Johnson & Johnson's baby products are sold at a supermarket Thursday, March 19, 2009 in Shanghai, China. Shanghai's food and drug safety agency says it is testing Johnson & Johnson baby products following allegations they contain potential carcinogens.
View Photo »A customer looks at Johnson & Johnson's baby products sold at a supermarket Thursday, March 19, 2009 in Shanghai, China. Shanghai's food and drug safety agency says it is testing Johnson & Johnson baby products following allegations they contain potential carcinogens.
View Photo »Johnson & Johnson's baby products are sold at a supermarket Thursday, March 19, 2009 in Shanghai, China. Shanghai's food and drug safety agency says it is testing Johnson & Johnson baby products following allegations they contain potential carcinogens.
View Photo »A baby is bathed as a bottle of Johnson & Johnson's baby product stands in foreground at a baby care center in Xiangfan, in central China's Hubei province, on Monday, March 16, 2009.
View Photo »NEW BRUNSWICK, NJ - NOVEMBER 03: Johnson & Johnson corporate headquarters are seen November 3, 2009 in New Brunswick, New Jersey. The world's biggest health-products company announced it will cut up to 8,000 jobs in the struggling economy.
View Photo »NEW BRUNSWICK, NJ - NOVEMBER 03: Johnson & Johnson corporate headquarters are seen November 3, 2009 in New Brunswick, New Jersey. The world's biggest health-products company announced it will cut up to 8,000 jobs in the struggling economy.
View Photo »NEW BRUNSWICK, NJ - NOVEMBER 03: Johnson & Johnson corporate headquarters are seen November 3, 2009 in New Brunswick, New Jersey. The world's biggest health-products company announced it will cut up to 8,000 jobs in the struggling economy.
View Photo »WASHINGTON - NOVEMBER 02: Queen Noor of Jordan speaks during a reception to honor Johnson & Johnson for it's work with SOS at the Austrian Embassy on November 2, 2009 in Washington DC.
View Photo »WASHINGTON - NOVEMBER 02: Queen Noor of Jordan speaks during a reception to honor Johnson & Johnson for it's work with SOS at the Austrian Embassy on November 2, 2009 in Washington DC.
View Photo »WASHINGTON - NOVEMBER 02: (L-R) Dr. Heather Paul of SOS, Queen Noor of Jordan and Ambassador of Austria, Dr. Christian Prosl speak during a reception to honor Johnson & Johnson for it's work with SOS at the Austrian Embassy on November 2, 2009 in Washington DC.
View Photo »WASHINGTON - NOVEMBER 02: Queen Noor of Jordan speaks during a reception to honor Johnson & Johnson for it's work with SOS at the Austrian Embassy on November 2, 2009 in Washington DC.
View Photo »WASHINGTON - NOVEMBER 02: Queen Noor of Jordan speaks during a reception to honor Johnson & Johnson for it's work with SOS at the Austrian Embassy on November 2, 2009 in Washington DC.
View Photo »WASHINGTON - NOVEMBER 02:Ambassador of Austria, Dr. Christian Prosl speaks during a reception to honor Johnson & Johnson for it's work with SOS at the Austrian Embassy on November 2, 2009 in Washington DC.
View Photo »WASHINGTON - NOVEMBER 02: Queen Noor of Jordan and Ambassador of Austria, Dr. Christian Prosl stand during a reception to honor Johnson & Johnson for it's work with SOS at the Austrian Embassy on November 2, 2009 in Washington DC.
View Photo »WASHINGTON - NOVEMBER 02: SOS CEO Dr.Heather Paul and Ambassador of Austria, Dr. Christian Prosl speak during a reception to honor Johnson & Johnson for it's work with SOS at the Austrian Embassy on November 2, 2009 in Washington DC.
View Photo »WASHINGTON - NOVEMBER 02:Ambassador of Austria, Dr. Christian Prosl speaks during a reception to honor Johnson & Johnson for it's work with SOS at the Austrian Embassy on November 2, 2009 in Washington DC.
View Photo »WASHINGTON - NOVEMBER 02: Queen Noor of Jordan speaks during a reception to honor Johnson & Johnson for it's work with SOS at the Austrian Embassy on November 2, 2009 in Washington DC.
View Photo »This undtaed handout photo provided by Johnson & Johnson shows an IBOT wheelchair.
View Photo »Just a week before announcing that Johnson & Johnson will cut some 8,000 jobs, J&J chair and chief executive Bill Weldon plunked down $8.45 million for two adjacent vacant waterfront lots in North Palm Beach, Fl
We like the stocks that we have such as Johnson & Johnson, Wells Fargo. Our thinking is that the stronger get stronger and good management will prevail. Look at the commercial/industrial mortgage problem. There are 100 regional banks in this and say they all go bankrupt. That means there’s opportunities...
We continue to differentiate ourselves from our peer group based on the strength of our financial position, our pipeline of potential first-in-class oncology products, our discovery prowess, and our balanced business strategy anchored in global partnerships with GlaxoSmithKline, Eisai and Johnson & John...
Due to the influenza A (H1N1) virus outbreak this past spring and resurgence this fall, Johnson & Johnson Consumer Companies Inc. has experienced heavy demand on supplies of Purell
Now companies like Amgen and Genentech and J & J [Johnson & Johnson] and other companies that you know are doing their logistics work right here from Louisville ... In fact, Genentech, the first investment made outside of the state of California was right here in Louisville and it was right here because...
The third quarter of 2009 proved to be a time of significant transformation for Elan. Completion of the Johnson & Johnson transaction and the subsequent refinancing of our balance sheet provide strategic flexibility and financial stability for the company.
Also, Johnson & Johnson came out with results that were in line with market expectations, and as we know Alcoa set a very high benchmark and the market expects more. There are some big companies still to release their results tonight and for the rest of the week. We will eye those and see what happens. ...
New blog post: Johnson & Johnson First Aid Kit, Safe Travels (Pack of 2) http://bit.ly/8oD4gv
- buying4cheap 59 minutes ago
#health #healthcare Johnson & Johnson unit's HIV drug approved http://bit.ly/5Cp9US
- healthcareintl 1 hour ago
#health #healthcare Johnson & Johnson unit's HIV drug approved http://bit.ly/5Cp9US
- healthnewsblogs 1 hour ago
- HaifaUniversity
3 hours ago
fresh out da shower!...yeah buddy..smellin like johnson johnson
- Mz_Tinkabell 3 hours ago